» Authors » Frieder Fuchs

Frieder Fuchs

Explore the profile of Frieder Fuchs including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 436
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nirca V, Fuchs F, Burgwinkel T, Del Pino R, Zaharcenco E, Hagen R, et al.
Microorganisms . 2025 Feb; 13(2). PMID: 40005787
Information on the molecular epidemiology and carbapenem resistance mechanisms in Gram-negative bacterial isolates in Moldova is scarce. To close this knowledge gap, carbapenem-resistant Gram-negative bacteria were collected over an 11-month...
2.
Fuchs F, Xanthopoulou K, Burgwinkel T, Del Pino R, Wohlfarth E, Pavlu F, et al.
J Glob Antimicrob Resist . 2024 Oct; 39:184-188. PMID: 39419442
Objective: To molecularly characterize several extensively drug-resistant isolates from a single hospital admission screening of a war-injured patient from Ukraine. Methods: Admission screening included swabs from skin, wounds, catheters, nasopharyngeum...
3.
Fuchs F, Frickmann H, Hahn A, Balczun C, Hagen R, Feldt T, et al.
J Med Microbiol . 2024 Oct; 73(10). PMID: 39392223
. Fungal infections are relevant health risks for individuals with acquired immunodeficiency in the resource-limited tropics, but available surveillance data are scarce. For and spp., the evolution from environmental reservoirs...
4.
Bohm L, Schaller M, Balczun C, Kruger A, Schummel T, Ammon A, et al.
Infect Dis Rep . 2024 Aug; 16(4):699-706. PMID: 39195004
Here, we report the simultaneous isolation of from blood cultures and from a skin ulcer in an elderly woman who suffered from atopic dermatitis and psoriasis and developed acute cellulitis...
5.
Rodriguez-Exposito R, Sifaoui I, Reyes-Batlle M, Fuchs F, Scheid P, Pinero J, et al.
Antioxidants (Basel) . 2023 Dec; 12(12). PMID: 38136200
is a ubiquitous genus of amoebae that can act as opportunistic parasites in both humans and animals, causing a variety of ocular, nervous and dermal pathologies. Despite advances in therapy,...
6.
Chao-Pellicer J, Arberas-Jimenez I, Fuchs F, Sifaoui I, Pinero J, Lorenzo-Morales J, et al.
Antibiotics (Basel) . 2023 Aug; 12(8). PMID: 37627700
Among the pathogenic free-living amoebae (FLA), is the etiological agent of a fatal disease known as primary amoebic meningoencephalitis (PAM). Once infection begins, the lesions generated in the central nervous...
7.
Hamprecht A, Sattler J, Noster J, Stelzer Y, Fuchs F, Dorth V, et al.
Clin Microbiol Infect . 2023 Jun; 29(9):1198.e1-1198.e6. PMID: 37271195
Objectives: To analyse carbapenemases in Proteus mirabilis and assess the performance of carbapenemase detection assays. Methods: Eighty-one clinical P. mirabilis isolates with high-level resistance at least to ampicillin (>32 mg/L)...
8.
Peng L, Li Y, Yao S, Gaedcke J, Baart V, Sier C, et al.
Cancers (Basel) . 2023 Mar; 15(5). PMID: 36900379
Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers. Given the currently limited therapeutic options, the definition of molecular subgroups with the development of tailored therapies remains...
9.
Ahmadzada A, Fuchs F, Hamprecht A
Microbiol Spectr . 2023 Feb; :e0276322. PMID: 36847493
Aerococcus urinae and Aerococcus sanguinicola have been increasingly recognized as causative agents of urinary tract infection (UTI) during the last decade. Nitroxoline achieves high urinary concentrations after oral administration and...
10.
Hoffmann A, Wolke M, Rybniker J, Plum G, Fuchs F
J Glob Antimicrob Resist . 2023 Feb; 33:1-4. PMID: 36842457
Objectives: The old antimicrobial nitroxoline is approved to treat urinary tract infection (UTI) and is currently rediscovered for treatment of drug resistant pathogens. Mycobacteria of the Mycobacterium abscessus complex (MYABS)...